NEW YORK, March 31, 2016 -- TransPerfect, the world’s largest provider of language services and content management technology to the medical device industry, today announced the introduction of its EnCompass system for digital labeling and content management. Built on validated technology and patented processes, the EnCompass system helps medical device manufacturers reduce the costs, risk, and turnaround times for labeling translation by up to 50%, while improving quality up to 300%. For more information, visit: www.transperfect.com/meddev.
|
|||
Device makers are faced with an increasingly risky regulatory environment, decreased product cycle times, and an explosion of product content that requires output to multiple formats. To cope with this proliferation of content, manufacturers are turning to XML and component content management technology.
According to Marc Miller, Division President of TransPerfect Medical Device Solutions, “Our EnCompass system is in use with the world’s largest device manufacturers to dramatically reduce cost, risk, and turnaround. On a recent project, one of our clients used XML technology to produce over 5,000 pages of technical manuals in just eight business days!”
System ROI Within One Year…or Less!
TransPerfect’s EnCompass System is an integrated combination of modular, validated technologies and patented processes that provides device makers with remarkable cost savings and risk management for their English-language and translated content:
- Guided Authoring – Enables authors to automatically write simpler, more compact English and reuse previously translated content for lower cost and increased consistency.
- Translation Management – The system’s translation process automation component makes workflows and linguistic assets available to teams worldwide. A browser-based QC portal allows reviewers to view formatted content and make edits in real time, while maintaining compliance with an electronic audit trail.
- XML/CCMS – The system’s XML component content management module is the most widely-adopted in the medical device industry. XML helps automate publishing processes and supports a single-source information architecture for dramatic decreases in content cost, turnaround, and risk.
- Patented, ISO 13485/ISO 14971-Certified Services – TransPerfect Medical Device Solutions holds the world’s only patent for medical device translation risk management. Its unique approach to risk management ensures quality and accuracy when publishing to multilingual formats.
Notes Miller, “Versus traditional processes for document authoring, translation, and formatting, our EnCompass System is revolutionary. Because we’re converting manufacturers from highly manual to highly automated processes, system ROI is generally less than one year.”
Because XML systems drive reuse and consistency through “single source” architecture, the value of TransPerfect’s patented, ISO 13485/ISO 14971-certified translation processes are extremely important for high-quality multilingual publication—whatever the output channel.
About TransPerfect Medical Device Solutions
TransPerfect Medical Device Solutions is the specialized medical device division of TransPerfect. With annual revenues of more than $500 million, TransPerfect is the world's largest provider of language services and content management technology to the medical device industry. From offices in more than 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and EN 15038 certified across all offices. The Medical Device Solutions group is also certified to ISO 13485 and ISO 14971. For more information, please visit our website at: www.transperfect.com/meddev.
Contact: Marc H. Miller +1 617.597.1984 [email protected] www.transperfect.com/meddev


Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 



